Financial information publisher and events organiser Euromoney Institutional Investor (LON: ERM) is releasing its third quarter trading statement on Wednesday. This should provide information on the progress of the performance improvement strategy.

The announcement will be combined with a capital markets day for investors.


Interim revenues decline due to disposals, but organic growth was 1%. This rate of growth should accelerate, and the latest quarter will provide some indications about whether or not that is happening yet.

Price reporting and analytics business Fastmarkets is likely to help medium-term growth


The London Medical Exchange (LME) is adopting Fastmarkets pricing for lithium contracts. The LME says that the fact the prices were widely used, and the capabilities of the service were behind its decision.

The idea is to use the pricing throughout the supply chain and enable the development of risk-management tools.

Increasing demand for lithium for the battery industry will provide demand for the information. Electric vehicles have particularly added interest to the lithium market. Fastmarkets already provides the benchmark for the cobalt market, another metal that is subject to demand from the battery industry.

Full year

Analysts still expect underlying 2018-19 pre-tax profit to decline from £109m to around £103m.

At 1352p a share, Euromoney is trading on 18 times prospective earnings.